Where Mid-Regional pro-Atrial Natriuretic Peptide (MR-proANP) is reported
| Condition | Direction | Compared against | Associated symptoms | Source |
|---|---|---|---|---|
| Atrial Fibrillation | ↑ elevated | patients in sinus rhythm (SR) | — | Sramko et al. 2019 |
Frequently asked questions
In which conditions is Mid-Regional pro-Atrial Natriuretic Peptide (MR-proANP) altered?
In the OSMF atlas Mid-Regional pro-Atrial Natriuretic Peptide (MR-proANP) is reported in Atrial Fibrillation. It is elevated in 1 across 1 entries.
Is there a standard clinical test for Mid-Regional pro-Atrial Natriuretic Peptide (MR-proANP)?
The atlas entries for Mid-Regional pro-Atrial Natriuretic Peptide (MR-proANP) do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.
Is one abnormal Mid-Regional pro-Atrial Natriuretic Peptide (MR-proANP) result diagnostic?
No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.
Cite this page
Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.